Aptevo Therapeutics Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.20M | -6.41M | -6.31M | -5.10M | -5.88M |
| Total Depreciation and Amortization | 49.00K | 61.00K | 71.00K | 84.00K | 91.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -163.00K | 180.00K | -72.00K | 149.00K | 273.00K |
| Change in Net Operating Assets | -775.00K | -408.00K | 554.00K | -354.00K | -634.00K |
| Cash from Operations | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.36M | -- | 6.72M | 4.91M | 3.97M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 14.36M | -- | 6.72M | 4.91M | 3.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.27M | -6.58M | 961.00K | -313.00K | -2.18M |